Has-miR-133a-3p was involved in osteoclast formation, differentiation, apoptosis, and resorption, showing great promise as a potential therapeutic target for biomarkers and osteoporosis [31], and was found to regulate TGFBR2 and FHL1 expression in this study. The gene discussed is TGFBR2; the disease is osteoporosis.